179 related articles for article (PubMed ID: 10436698)
1. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
3. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
4. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
5. [A comparaison between the total PSA, the Gleason score and the bone scintiscan results for different age groups].
Rusu D; Rusu V; Stefănescu C; Rusu M; Răileanu I; Stătescu AM
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):476-83. PubMed ID: 20700990
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of serum prostate specific antigen levels and bone scintigraphy in patients with prostate carcinoma].
Bielickaite J; Zadeikaite R; Jurkiene N; Kiudelis J; Kuprionis G
Medicina (Kaunas); 2003; 39(9):867-71. PubMed ID: 14515049
[TBL] [Abstract][Full Text] [Related]
7. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum prostate specific antigen levels and bone scintigraphy in carcinoma prostate.
Oommen R; Geethanjali FS; Gopalakrishnan G; Chacko N; John S; Kanagasabapathy AS; Roul RK
Br J Radiol; 1994 May; 67(797):469-71. PubMed ID: 7514940
[TBL] [Abstract][Full Text] [Related]
9. Association of prostate-specific antigen levels and patterns of benign and malignant uptake detected. on bone scintigraphy in patients with newly diagnosed prostate carcinoma.
Jacobson AF
Nucl Med Commun; 2000 Jul; 21(7):617-22. PubMed ID: 10994663
[TBL] [Abstract][Full Text] [Related]
10. [Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma].
Kliment J; Eliás B; Svihra J
Rozhl Chir; 1994 Sep; 73(6):300-2. PubMed ID: 7536351
[TBL] [Abstract][Full Text] [Related]
11. [The indication of bone scan for patients with newly diagnosed prostate cancer].
Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
[TBL] [Abstract][Full Text] [Related]
12. Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer.
Singh OP; Yogi V; Redhu P; Ghori HU; Pareek A; Lal N
J Cancer Res Ther; 2019 Mar; 15(Supplement):S39-S41. PubMed ID: 30900618
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
14. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?].
Ruiz de la Roja JC; Llorente Abarca C; Romero Cagigal I; Páez Borda A; Fernández González I; Martín Osés E; Berenguer Sánchez A
Actas Urol Esp; 1995 Feb; 19(2):123-7. PubMed ID: 7539572
[TBL] [Abstract][Full Text] [Related]
15. Can serum prostate-specific antigen replace bone scintigraphy in the follow-up of metastatic prostatic cancer?
Sissons GR; Clements R; Peeling WB; Penney MD
Br J Radiol; 1992 Oct; 65(778):861-4. PubMed ID: 1384917
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of serial isotope bone scans in prostate cancer.
O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
[TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.
Savelli G; Maffioli L; Maccauro M; De Deckere E; Bombardieri E
Q J Nucl Med; 2001 Mar; 45(1):27-37. PubMed ID: 11456373
[TBL] [Abstract][Full Text] [Related]
19. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
